The global Cerebrospinal Fluid Drainage Catheter market size is expected to be worth around US$ 461.75 Mn by 2030, according to a new report by Vision Research Reports.
The global Cerebrospinal Fluid Drainage Catheter market size was valued at US$ 260.34 Mn in 2020 and is anticipated to grow at a CAGR of 10.5% during forecast period 2021 to 2030.
Growth Factors
Increasing incidences of neurological disorders, coupled with a subsequent rise in the number of surgical procedures to treat associated conditions, are expected to drive the market.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38336
Increasing incidence of cranial and spinal injuries, trauma, and other inflammatory diseases of the cerebrospinal space is expected to promote market growth over the forecast period. For instance, as per the National Spinal Cord Injury Statistical Center estimates in 2020, approximately 294,000 Americans are currently living with SCI and 17,810 new cases of SCI are reported each year.
However, the COVID-19 emergency has negatively impacted the current market for Cerebrospinal Fluid (CSF) drainage catheters in various conducts, such as shortage of healthcare professionals and treatments for individuals suffering from neurological disorders or other medical illness during the COVID-19 pandemic. In addition, the supply chain, manufacturing activities, delivery schedules, and sales of neurological products have been disrupted owing to the restrictions at international borders, thereby affecting the market growth for the short term.
Report Highlights
In 2020, the ventricular drainage catheter segment dominated the market with a share of over 80.0% and is expected to expand at the highest CAGR from 2021 to 2030. The high incidence rate of intraventricular hemorrhage and traumatic brain injuries, which may lead to intracranial bleeding (hemorrhage), is increasing the use of ventricular drain catheters to remove excess cerebrospinal fluid from the brain. According to the CDC, cerebral hemorrhage is the second leading cause of stroke in the U.S. and accounts for about 13% of all strokes. Similarly, as per the World Stroke Organization (WSO) fact sheet, there are over 23.7 million new strokes reported each year globally.
The traumatic brain injury segment dominated the market with a share of over 50.0% in 2020 and is expected to exhibit the highest CAGR from 2021 to 2030. The high prevalence rate of TBIs owing to road mishaps, the act of violence, or fall is expected to propel the growth of the segment during the forecast period. This leads to hospitalization and lasting disability for thousands of individuals every year globally. For instance, as per the Brain and Spine Institute, every year in France, approximately 180,000 people suffer from traumatic brain injuries, which include mild and severe injuries. More than 12,000 people become permanently disabled post brain injuries. Similarly, as per the WHO report, a road-traffic mortality rate of 36.6 deaths per 120,000 population has been registered in Africa. This is projected to support the segment growth over the forecast period..
North America dominated the market with a share of over 45.0% in 2020. This is attributed to the high incidence and prevalence of traumatic brain and spinal injuries as well as neurovascular disorders, such as intraventricular hemorrhage and ischemic strokes. For instance, according to the 2020 SCI Data Sheet from the National SCI Statistical Center (NSCISC), every year, around 17,810 new spinal cord injuries are reported in the U.S., which accounts for approximately 54 cases per one million people. Vehicle crashes (48.6%) are currently the leading cause of spinal injury, followed by falls (42.2%), violence (24.0%), and sports/recreation activities (10.8%). Moreover, the presence of a well-developed healthcare sector and major medical device companies, such as Medtronic, Natus Medical, and Integra LifeSciences, are contributing to the market growth in the region. Thus, the high prevalence of neurovascular disorders and injuries and the growing awareness among individuals regarding illness and treatment are driving the market in this region.
| Report Coverage | Details |
| Market Size | US$ 461.75 Mn by 2030 |
| Growth Rate | CAGR of 10.5% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Natus Medical, Inc.; Desu Medica; Spiegelberg GmbH & Co. KG; Integra LifeSciences Corporation; Medtronic; Moller Medical GmbH; Sophysa SA |
Key Players
Market Segmentation
Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38336 or call: +1 9197 992 333
Vision Research Report, Recently Announced New Report on "Smart Lock market - Global Industry Analysis,…
Vision Research Report, Recently Announced New Report on "2D barcode reader market - Global Industry…
Vision Research Report, Recently Announced New Report on "commercial refrigeration equipment market - Global Industry…
Vision Research Report, Recently Announced New Report on "Restaurant Point-of-Sale Terminal market - Global Industry…
Vision Research Report, Recently Announced New Report on "vacuum cleaner market- Global Industry Analysis, Market…
Vision Research Report, Recently Announced New Report on "household refrigerators and freezers market - Global…